New Zealand-born Matthew During was a pioneering neuroscientist who devoted his life to developing gene therapy for human applications. During, who died in Darien, Connecticut on January 26th, 2023, aged 66. He made…
A new study co-authored by two NZ researchers suggests that long-term, moderate alcohol consumption can help improve the memory. The study, which was published in The Journal of Neuroscience, was undertaken by Maggie Kalev, a research fellow…
A groundbreaking study by NZ neuroscientist Matt During has been applauded in leading British medical journal, The Lancet. During has pioneered a controversial gene therapy for Parkinson’s Disease that involved inserting synthetic copies of human genes…
Dr Matthew During of Auckland University is part of a US medical team promoting the groundbreaking use of gene therapy in the treatment of Parkinson’s disease. Speaking in New York, During emphasised that the procedure was…
Gene therapist Matt During and his team of trans-pacific researchers have announced a “significant advance” in their search for a potentially revolutionary treatment for Parkinson’s disease. Published in the prestigious journal Science the findings derive from a technique…
Edge Gene Therapist and Professor of Neurosurgery at the Jefferson Medical College Philadelphia Matthew During, releases a first and major step forward in the prevention and possible treatment of stomach cancers through a technique involving oral doses…
Kiwi Dr. Matthew During, in articles published in the New Yorker and Science reveals ‘revolutionary’ research that could limit brain damage caused by epilepsy and strokes.
Contact | Privacy | Terms of Service | Advertise | Google+ © Copyright NZEDGE 1998-2024
